| Application number | Title of the application | Filing Date | Status |
|---|
| 09/631579 | Method for treating hepatitis C | Aug 3, 2000 | Abandoned |
| 09/601596 | PHARMACEUTICAL COMPOSITIONS IN FORM OF NANOPARTICLES COMPRISING LIPIDIC SUBSTANCES AND AMPHIPHILIC SUBSTANCES AND RELATED PREPARATION PROCESS | Aug 3, 2000 | Abandoned |
Array
(
[id] => 1534866
[patent_doc_number] => 06489297
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Vasoactive intestinal peptide analogs'
[patent_app_type] => B1
[patent_app_number] => 09/630335
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6495
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489297.pdf
[firstpage_image] =>[orig_patent_app_number] => 09630335
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/630335 | Vasoactive intestinal peptide analogs | Jul 30, 2000 | Issued |
Array
(
[id] => 1413606
[patent_doc_number] => 06509039
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-01-21
[patent_title] => 'Crosslinked products of biopolymers containing amino groups'
[patent_app_type] => B1
[patent_app_number] => 09/621343
[patent_app_country] => US
[patent_app_date] => 2000-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1548
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09621343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/621343 | Crosslinked products of biopolymers containing amino groups | Jul 20, 2000 | Issued |
| 09/620691 | Method for stabilization of proteins using non-natural amino acids | Jul 19, 2000 | Abandoned |
| 09/618175 | Tetrapeptide | Jul 17, 2000 | Abandoned |
Array
(
[id] => 754164
[patent_doc_number] => 07018841
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-28
[patent_title] => 'Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles'
[patent_app_type] => utility
[patent_app_number] => 09/613170
[patent_app_country] => US
[patent_app_date] => 2000-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 12856
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018841.pdf
[firstpage_image] =>[orig_patent_app_number] => 09613170
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/613170 | Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles | Jul 9, 2000 | Issued |
Array
(
[id] => 729157
[patent_doc_number] => 07041800
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-09
[patent_title] => 'Preserving a hemoglobin blood substitute with a transparent overwrap'
[patent_app_type] => utility
[patent_app_number] => 10/018599
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12950
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018599 | Preserving a hemoglobin blood substitute with a transparent overwrap | Jul 6, 2000 | Issued |
Array
(
[id] => 729147
[patent_doc_number] => 07041799
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-09
[patent_title] => 'Preserving a hemoglobin blood substitute with a transparent overwrap'
[patent_app_type] => utility
[patent_app_number] => 10/018529
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13569
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018529
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018529 | Preserving a hemoglobin blood substitute with a transparent overwrap | Jul 6, 2000 | Issued |
Array
(
[id] => 914476
[patent_doc_number] => 07326680
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-02-05
[patent_title] => 'Uterine contraction inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/030298
[patent_app_country] => US
[patent_app_date] => 2000-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6978
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030298 | Uterine contraction inhibitors | Jun 22, 2000 | Issued |
Array
(
[id] => 1111395
[patent_doc_number] => 06806284
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Photosensitizers with ligand targeting properties for tumor therapy'
[patent_app_type] => B1
[patent_app_number] => 09/599660
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2913
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09599660
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/599660 | Photosensitizers with ligand targeting properties for tumor therapy | Jun 21, 2000 | Issued |
Array
(
[id] => 1419696
[patent_doc_number] => 06518406
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Method for purification of proteins'
[patent_app_type] => B1
[patent_app_number] => 09/598883
[patent_app_country] => US
[patent_app_date] => 2000-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5494
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518406.pdf
[firstpage_image] =>[orig_patent_app_number] => 09598883
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/598883 | Method for purification of proteins | Jun 20, 2000 | Issued |
| 09/596593 | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid | Jun 18, 2000 | Abandoned |
Array
(
[id] => 1470121
[patent_doc_number] => 06407059
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-18
[patent_title] => 'Conformationally constrained backbone cyclized peptide analogs'
[patent_app_type] => B1
[patent_app_number] => 09/580905
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28686
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/407/06407059.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580905 | Conformationally constrained backbone cyclized peptide analogs | May 30, 2000 | Issued |
Array
(
[id] => 1150199
[patent_doc_number] => 06770623
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-03
[patent_title] => 'Stabilized teriparatide solutions'
[patent_app_type] => B1
[patent_app_number] => 09/555476
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2902
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770623.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555476 | Stabilized teriparatide solutions | May 30, 2000 | Issued |
Array
(
[id] => 1123719
[patent_doc_number] => 06794362
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Asparagine containing elastin peptide analogs'
[patent_app_type] => B1
[patent_app_number] => 09/580893
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10569
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794362.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580893
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580893 | Asparagine containing elastin peptide analogs | May 29, 2000 | Issued |
Array
(
[id] => 1153918
[patent_doc_number] => 06767994
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-27
[patent_title] => 'Process for purifying a compound'
[patent_app_type] => B1
[patent_app_number] => 09/571683
[patent_app_country] => US
[patent_app_date] => 2000-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10692
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767994.pdf
[firstpage_image] =>[orig_patent_app_number] => 09571683
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/571683 | Process for purifying a compound | May 15, 2000 | Issued |
Array
(
[id] => 695834
[patent_doc_number] => 07071313
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => 'Methods of purifying authentic IGF from yeast hosts'
[patent_app_type] => utility
[patent_app_number] => 09/564414
[patent_app_country] => US
[patent_app_date] => 2000-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10427
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09564414
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/564414 | Methods of purifying authentic IGF from yeast hosts | May 1, 2000 | Issued |
Array
(
[id] => 679961
[patent_doc_number] => 07084107
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-01
[patent_title] => 'Methods for stabilizing liquid nutritional products and products so stabilized'
[patent_app_type] => utility
[patent_app_number] => 09/959131
[patent_app_country] => US
[patent_app_date] => 2000-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2899
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084107.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959131
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959131 | Methods for stabilizing liquid nutritional products and products so stabilized | Apr 12, 2000 | Issued |
Array
(
[id] => 1173265
[patent_doc_number] => 06750201
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-15
[patent_title] => 'Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator'
[patent_app_type] => B1
[patent_app_number] => 09/544665
[patent_app_country] => US
[patent_app_date] => 2000-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 14974
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750201.pdf
[firstpage_image] =>[orig_patent_app_number] => 09544665
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/544665 | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator | Apr 5, 2000 | Issued |